Biofil Chemicals & Pharmaceuticals has informed that pursuant to provision of Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the Company submitted details of issued duplicate share certificates received from its Registrar on 8th March 2021.
The above information is a part of company’s filings submitted to BSE.